Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M2-BFs for Developmental Speech Disorders
NCT04689282Phase 2Completed
- Sponsor
- Russian Academy of Sciences
- Start
- Feb 2020
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
A Phase 2 trial of M2-BFs in language delay, expressive language disorder, Receptive Language Disorder, Autism Spectrum Disorder (ASD), attention deficit hyperactivity disorder (ADHD), sponsored by Russian Academy of Sciences. Started Feb 2020; status: completed.
02
Drugs
M2-BFs
03
Conditions
language delayexpressive language disorderReceptive Language DisorderAutism Spectrum Disorder (ASD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04689282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04689282.